Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Halfvarson

Showing results (141-150 of 244) with videos related to

Pageof 25
Sort By:
Crohn'S & Colitis 360|March 20, 2023
The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel DiseaseJamie M Horrigan, Edouard Louis, Antonino Spinelli, et al.
World Journal of Gastroenterology|December 1, 2012
Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealedKristin Blom, Jenny Rubin, Jonas Halfvarson, et al.
Alimentary Pharmacology & Therapeutics|August 23, 2021
Editorial: infliximab or adalimumab as first- or second-line anti-TNF-conflicting evidence-authors' replyIsabella Visuri, Carl Eriksson, Ola Olén, et al.
Alimentary Pharmacology & Therapeutics|July 21, 2021
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality registerIsabella Visuri, Carl Eriksson, Ola Olén, et al.
The ISME Journal|October 31, 2008
Shotgun metaproteomics of the human distal gut microbiotaNathan C Verberkmoes, Alison L Russell, Manesh Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2025
Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieuCaroline Boulouis, Elli Mouchtaridi, Thomas R Müller, et al.
United European Gastroenterology Journal|July 14, 2022
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality registerJoel Thunberg, Olle Björkqvist, Charlotte R H Hedin, et al.
Inflammatory Bowel Diseases|May 15, 2013
Subclinical inflammation with increased neutrophil activity in healthy twin siblings reflect environmental influence in the pathogenesis of inflammatory bowel diseaseYaroslava Zhulina, Victoria Hahn-Strömberg, Alia Shamikh, et al.
Plos One|August 27, 2013
Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's DiseaseKarin Fransén, Petra Franzén, Anders Magnuson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort StudyOla Olén, Karin E Smedby, Rune Erichsen, et al.
Pageof 25

Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Crohn'S & Colitis 360|March 20, 2023
The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel DiseaseJamie M Horrigan, Edouard Louis, Antonino Spinelli, et al.
World Journal of Gastroenterology|December 1, 2012
Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealedKristin Blom, Jenny Rubin, Jonas Halfvarson, et al.
Alimentary Pharmacology & Therapeutics|August 23, 2021
Editorial: infliximab or adalimumab as first- or second-line anti-TNF-conflicting evidence-authors' replyIsabella Visuri, Carl Eriksson, Ola Olén, et al.
Alimentary Pharmacology & Therapeutics|July 21, 2021
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality registerIsabella Visuri, Carl Eriksson, Ola Olén, et al.
The ISME Journal|October 31, 2008
Shotgun metaproteomics of the human distal gut microbiotaNathan C Verberkmoes, Alison L Russell, Manesh Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2025
Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieuCaroline Boulouis, Elli Mouchtaridi, Thomas R Müller, et al.
United European Gastroenterology Journal|July 14, 2022
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality registerJoel Thunberg, Olle Björkqvist, Charlotte R H Hedin, et al.
Inflammatory Bowel Diseases|May 15, 2013
Subclinical inflammation with increased neutrophil activity in healthy twin siblings reflect environmental influence in the pathogenesis of inflammatory bowel diseaseYaroslava Zhulina, Victoria Hahn-Strömberg, Alia Shamikh, et al.
Plos One|August 27, 2013
Polymorphism in the retinoic acid metabolizing enzyme CYP26B1 and the development of Crohn's DiseaseKarin Fransén, Petra Franzén, Anders Magnuson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort StudyOla Olén, Karin E Smedby, Rune Erichsen, et al.
Pageof 25